The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Novel Roles of Unphosphorylated STAT3 in Oncogenesis and Transcriptional Regulation
Open accessAbstract
Signal transducer and activator of transcription 3 (STAT3) is phosphorylated on tyrosine residue 705 in response to growth factors or cytokines to form activated homodimers that drive gene expression. Because the stat3 promoter has a binding site for STAT3 dimers, the amount of STAT3 protein increases when STAT3 is activated (e.g., in response to interleukin 6). Unphosphorylated STAT1 is known to drive the expression of certain genes. To explore the possibility of a similar role for the induced expression of unphosphorylated STAT3, we overexpressed either Y705F STAT3, which can not be phosphorylated on residue 705, or wild-type STAT3 in normal human mammary epithelial cells or STAT3-null mouse cells. The levels of many mRNAs were affected strongly by high levels of either form of STAT3. Some genes whose expression was increased by overexpressed STAT3, but not by activated STAT3 dimers, encode well-known oncoproteins (e.g., MRAS and MET). In many tumors, STAT3 is activated constitutively, and thus the unphosphorylated form is likely to be expressed highly, driving oncogene expression by a novel mechanism. In addition, expression of the stat3 gene is increased strongly in response to interleukin 6, and the high levels of unphosphorylated STAT3 that result drive a substantial late phase of gene expression in response to this cytokine. Thus, unphosphorylated STAT3, which activates gene expression by a novel mechanism distinct from that used by STAT3 dimers, is very likely to be an important transcription factor both in cancer and in responses to cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, their efficacy is diminished because the inherent transcriptional activity of unphosphorylated STAT3 could also drive the expression of oncogenes such as MET and MRAS by binding to NF-κB (18–21).”
From Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer (2022) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Second, the targeted STAT3 degradation can completely inhibit the transcriptional activity of both dimerized and monomeric STAT3 (19, 21, 26).”
From Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer (2022) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“and that basal STAT3 has been shown to have transcriptional activity under basal conditions [44,45]”
From Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes (2012) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Der, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,840
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Specific Inhibition of Stat3 Signal Transduction by PIAS3
Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., & Shuai, K. (1997) · Science · doi:10.1126/science.278.5344.1803 · Cited by 980
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Three-dimensional structure of the Stat3β homodimer bound to DNA
Becker, S., Groner, B., & Müller, C. W. (1998) · Nature · doi:10.1038/28101 · Cited by 802
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Crystal Structure of a Tyrosine Phosphorylated STAT-1 Dimer Bound to DNA
Chen, X., Vinkemeier, U., Zhao, Y., Jeruzalmi, D., Darnell, J. E., Jr., & Kuriyan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81443-9 · Cited by 734
Regulation of the cyclin E gene by transcription factor E2F1.
Ohtani, K., DeGregori, J. V., & Nevins, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12146 · Cited by 640
The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.
Wagner, B. J., Hayes, T. E., Hoban, C. J., & Cochran, B. H. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07898.x · Cited by 592
Research works printed but not linked: 1
- Reddy MVR, Chaturvedi P, Reddy EP. Src kinase mediated activation of STAT3 plays an essential role in the proliferation and oncogenicity of human breast, prostate and ovarian carcinomas. Proc AACR 1999;40:376.
Cited by
Sorted by citations
Items 301–400 of 404
Nowak, E., Poczęta, M., Bieg, D., & Bednarek, I. A. (2017) · Ginekologia Polska · doi:10.5603/gp.a2017.0099 · Cited by 13
Wang, J., Zhou, M., Jin, X., Li, B., Wang, C., Zhang, Q., Liao, M., Hu, X., & Yang, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29159 · Cited by 13
Woock, A. E., Grible, J. M., Olex, A. L., Harrell, J. C., Zot, P., Idowu, M. O., & Clevenger, C. V. (2021) · Scientific Reports · doi:10.1038/s41598-021-92830-8 · Cited by 13
Xander, P. B., Brito, R. R. N. E., Pérez, E. C., Pozzibon, J. M., de Souza, C. F., Pellegrino, R., Bernardo, V., Jasiulionis, M. G., Mariano, M., & Lopes, J. D. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.04.017 · Cited by 13
Nallar, S. C., Kalakonda, S., Sun, P., Ohmori, Y., Hiroi, M., Mori, K., Lindner, D. J., & Kalvakolanu, D. V. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091280 · Cited by 13
Prabhavathy, D., Prabhakar, B., & Karunagaran, D. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2083-6 · Cited by 14
Guo, X., Mao, X., Tian, D., Liao, Y., Su, B., Ye, C., Shi, D., Liu, T. F., Ling, Y., & Hao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.872286 · Cited by 13
STAT3 activates the anti-apoptotic form of caspase 9 in oncovirus-infected B lymphocytes
Koganti, S. R. K., Burgula, S., & Bhaduri‐McIntosh, S. (2019) · Virology · doi:10.1016/j.virol.2019.11.017 · Cited by 12
Deb, R., Sengar, G. S., Sonowal, J., Pegu, S. R., Das, P. J., Singh, I., Chakravarti, S., Selvaradjou, A., Attupurum, N., Rajkhowa, S., et al. (2024) · Archives of Virology · doi:10.1007/s00705-023-05959-4 · Cited by 11
Tang, H.-X., Qin, X.-P., & Li, J. (2020) · Vascular · doi:10.1177/1708538120929504 · Cited by 11
Thakur, K., Janjua, D., Aggarwal, N., Chhokar, A., Yadav, J., Tripathi, T., Chaudhary, A., Senrung, A., Shrivastav, A., & Bharti, A. C. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166817 · Cited by 11
Gough, D. J., Sehgal, P. B., & Levy, D. E. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0891-8_6 · Cited by 11
Self-citationJohnston, P. A., Sen, M., Hua, Y., Camarco, D. P., Shun, T. Y., Lazo, J. S., & Grandis, J. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7357-6_14 · Cited by 11
Cardioplegia and Diazoxide Modulate STAT3 Activation and DNA Binding
Hsieh, Y.-J., Wakiyama, H., Levitsky, S., & McCully, J. D. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.05.014 · Cited by 11
Urinary Retention, Incontinence, and Dysregulation of Muscarinic Receptors in Male Mice Lacking Mras
Ehrhardt, A., Wang, B., Yung, A. C., Wang, Y., Kozłowski, P., van Breemen, C., & Schrader, J. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141493 · Cited by 10
Poly(rC) Binding Protein 1 Represses the Translation of STAT3 through 5' UTR
Jia, R., Li, Z., & Wang, X. (2022) · Current Gene Therapy · doi:10.2174/1566523222666220511162934 · Cited by 10
Karim, A., Garg, R., Saikia, B., Tiwari, A., Sahu, S., Malhotra, M., Minz, R. W., Rawat, A. K., Singh, S., & Suri, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1332817 · Cited by 9
The effects of STAT3 acetylation on the transcriptional activity and tumorigenesis
Yan, H., Tang, L., Zhu, Y., & Zhang, Y. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117076 · Cited by 9
Advances in research on unphosphorylated STAT3: A review
Zhang, L., Guo, W., Lu, N., Tian, Y., Yang, J., & Wang, L. (2025) · Medicine · doi:10.1097/md.0000000000043476 · Cited by 10
Self-citationSenyuk, V. I., Rinaldi, C. R., Li, D., Cattaneo, F., Stojanović, A., Pane, F., Du, X., Mahmud, N., Dickstein, J. I., & Nucifora, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2534 · Cited by 9
Wu, N., Hui, H., Cui, L., & Yang, F. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.055 · Cited by 9
Xiong, C., Chen, Z., Wu, X., Zhang, C., Yuan, Z., Wang, X., Xiao, Z., Chen, Y., Deng, S., Wu, X., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178401 · Cited by 10
Targeting STAT3-mediated autophagy with small molecules in cancer treatment – A comprehensive review
Azad, S. M. A. K., Meem, J. N., Shaikat, A. H., Ali, M. L., Arif, M. S. R., Sabrin, S., Mostaq, M. S., Haque, M. R. U., Amin, M. N., & Mahmud, M. A. (2024) · Clinical Traditional Medicine and Pharmacology · doi:10.1016/j.ctmp.2024.200174 · Cited by 8
Wang, B. X., Platanias, L. C., & Fish, E. N. (2013) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0154 · Cited by 9
Control of signal transduction cycles: general results and application to the Jak-Stat pathway.
Beirer, S., & Höfer, T. (2006) · PubMed · Cited by 8
Krzyzanowska, A., Don‐Doncow, N., Marginean, F. E., Gaber, A., Watson, R. W. G., Hellsten, R., & Bjartell, A. S. (2019) · The Prostate · doi:10.1002/pros.23787 · Cited by 8
Absence of M-Ras modulates social behavior in mice
Ehrhardt, A., Wang, B., Leung, M., & Schrader, J. W. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0209-8 · Cited by 7
Finamore, E., Vitiello, M., D’Isanto, M., Galdiero, E., Falanga, A., Kampanaraki, A., Raieta, K., & Galdiero, M. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0158 · Cited by 7
Zhang, C., Wang, J., Song, X., Yu, D., Guo, B., Pang, Y., Yin, X., Zhao, S., Deng, H., Zhang, S., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02098-6 · Cited by 7
STAT3 promotes RNA polymerase III-directed transcription by controlling the miR-106a-5p/TP73 axis
Zhang, C., Zhao, S., Deng, H., Zhang, S., Wang, J., Song, X., Yu, D., Zhang, Y., & Deng, W. (2023) · eLife · doi:10.7554/elife.82826 · Cited by 7
NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma
Devitt, L., Westphal, D., Pieger, K., Schneider, N., Bosserhoff, A., & Kuphal, S. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01632-8 · Cited by 7
Diao, S., Li, L., Zhang, J., Ji, M.-L., Sun, L., Shen, W., Wu, S., Chen, Z., Huang, C., & Li, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116884 · Cited by 7
Muscle RAS oncogene homolog ( MRAS ) recurrent mutation in Borrmann type IV gastric cancer
Yasumoto, M., Sakamoto, E., Ogasawara, S., Isobe, T., Kizaki, J., Sumi, A., Kusano, H., Akiba, J., Torimura, T., Akagi, Y., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.959 · Cited by 6
Chiu, Y., Ku, P., Cheng, Y., Li, Y., Cheng, J., & Niu, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7973 · Cited by 6
Kuo, S., Li, Y., Cheng, K., Niu, C., Cheng, J., & Niu, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.115 · Cited by 6
Can asymmetric post‐translational modifications regulate the behavior of STAT3 homodimers?
Letra‐Vilela, R., Cardoso, B. M., Silva‐Almeida, C., Rocha, A. M., Murtinheira, F., Branco‐Santos, J., Rodrı́guez, C., Martı́n, V., Santa‐Marta, M., & Herrera, F. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00049 · Cited by 5
Helicobacter pylori and Cancer: What’s the Link?
Merola, E., Pes, G. M., Graham, D. Y., & Dore, M. P. (2026) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s495588 · Cited by 5
Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer
Masaki, C., Inoue, N., & Chiba, T. (2026) · Cells · doi:10.3390/cells15100884 · Cited by 5
Gong, K., ZHANG, H., Du, J., & Zhang, Y. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00525.x · Cited by 5
Diallo, M., Pimenta, C., Murtinheira, F., Martins-Alves, D., Pinto, F. R., da Costa, A. A., Letra‐Vilela, R., Martı́n, V., Rodrı́guez, C., Rodrigues, M. S., et al. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00911-9 · Cited by 5
STAT3 regulation of Mtb-specific T cell function in active pulmonary tuberculosis patients
Chen, R., Li, M., Qin, S., Lu, H., Shen, M., & Lin, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109748 · Cited by 4
Yan, H., Liu, Z., Lin, G., Gu, F., Liu, Y., Xu, Y., Kuang, X., & Zhang, Y. (2022) · Nano Research · doi:10.1007/s12274-022-4525-x · Cited by 4
Jak/STAT Signaling in Head and Neck Cancer
Cedars, E., Johnson, D. E., & Grandis, J. R. (2018) · Current cancer research · doi:10.1007/978-3-319-78762-6_6 · Cited by 4
Wu, S., Chen, X., Tang, Y., Zhang, Y., Li, D., Chen, J., Wang, J., Tang, Z., Zang, G., & Yongsheng, Y. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx133 · Cited by 4
The JAK–STAT–SOCS Signaling Cascade
Murphy, J. M., Babon, J. J., Nicola, N. A., & Nicholson, S. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30016-5 · Cited by 4
Yao, P., Ju, H., Song, A., Wang, Y., Xin, G., Wang, G., Ma, J., & Guo, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114629 · Cited by 3
Lazarte, J. M. S., Aare, M., Padakanti, S. C., Bagde, A., Nathani, A., Meeks, Z., Sun, L. J., Li, Y., & Singh, M. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101318 · Cited by 3
STAT3 as a predictive biomarker in head and neck cancer: A validation study
van Ruitenbeek, N. J., van der Woude, L. L., van Krieken, J. H., Grunsven, A. C. H. V. E., Willemsen, A. E. C. A. B., & van Herpen, C. M. L. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.153172 · Cited by 3
Morichika, K., Karube, K., Sakihama, S., Watanabe, R., Kawaki, M., Nishi, Y., Nakachi, S., Okamoto, S., Takahara, T., Satou, A., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001691 · Cited by 3
Ruiz‐Limón, P., Ladehesa-Pineda, L., López‐Medina, C., López-Pedrera, C., Abalos-Aguilera, M., Barbarroja, N., Arias-Quiros, I., Pérez‐Sánchez, C., de la Rosa, I. A., Castro, R. O., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11061037 · Cited by 3
How Stats Interact with the Molecular Machinery of Transcriptional Activation
Jamieson, A. M., Farlik, M., & Decker, T. (2012) · Springer eBooks · doi:10.1007/978-3-7091-0891-8_5 · Cited by 3
Challenging the “Undruggable”─Targeting STAT3 but Identifying Potent TrkA-Targeted Inhibitors
Iliev, P., McCutcheon, C., Admas, T. H., Reithmeier, A., McDonald, M. C. L., Outryve, A. V., Hanke, D., Brown, J. I., Haraldsson, M., Toillon, R., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00214 · Cited by 2
Effects of the Exposure of Human Non-Tumour Cells to Sera of Pancreatic Cancer Patients
Šabanović, B., Giulietti, M., Cecati, M., Spolverato, G., Benna, C., Pucciarelli, S., & Piva, F. (2022) · Biomedicines · doi:10.3390/biomedicines10102588 · Cited by 3
Remote Kidney and Liver Injury After Transplantation of Lung Allografts in an Allogeneic Mouse Model
Sander, M. L., Eulenburg, V., Maeyashiki, T., Jang, J., Müller, S. D., Stehr, S. N., Jungraithmayr, W., & Piegeler, T. (2024) · Transplantation Proceedings · doi:10.1016/j.transproceed.2024.10.020 · Cited by 2
Xu, H., Koganti, S. R. K., Li, C., McIntosh, M. T., & Bhaduri‐McIntosh, S. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013166 · Cited by 2
Role of STAT3 as a Negative Regulator in Mac2- Binding Protein Expression
Park, Y. P., Kim, J.-T., Yang, Y. D., Lim, J., Yoon, D. Y., Kim, J. W., & Lee, H. G. (2008) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2008.28.3.230 · Cited by 2
Vangara, B. S., & Grandis, J. R. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8815-6_8 · Cited by 2
Irshad, K., Madan, E., & Chosdol, K. (2016) · Springer eBooks · doi:10.1007/978-981-10-1711-7_10 · Cited by 2
Non-coding RNAs in Cardiomyopathy and Heart Failure
Holvoet, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-68844-8_6 · Cited by 2
Analysis of Potential Non-Canonical or Alternate STAT5 Functions in Immune Development and Growth
Awasthi, N. P., Ward, A. C., & Liongue, C. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2808187 · Cited by 2
O’Keefe, R. A., & Grandis, J. R. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-42949-6_2 · Cited by 2
New roles of STAT5 factors in chronic myeloid leukemia cell maintenance
Casetti, L. (2013) · theses.fr (ABES) · doi:10.70675/015b97bez21d7z47c6z92f5z071fb7a84bfc · Cited by 2
Toll-Like Receptors as Novel Therapeutic Targets for the Treatment of Pancreatic Cancer
Kelly, D., Benencia, F., Leonard, D., Malgor, R., Schwartz, A., & Frank, L. (2012) · InTech eBooks · doi:10.5772/27263 · Cited by 2
CXCL10 Induces Lytic Reactivation of EBV through EXTL1
Ding, B.-N., Wu, Y.-L., Zhang, Y.-Y., & Li, Y. (2024) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2024.1510039 · Cited by 1
Control of Signal Transduction Cycles
Beirer, S., & Höfer, T. (2006) · doi:10.11234/gi1990.17.152 · Cited by 1
STAT3 polymorphisms in North Africa and its implication in breast cancer
Ziadi, W., Boussetta, S., Elkamel, S., PAKSTIS, A. J., Kídd, K. K., Medimegh, I., Elgaaïed, A. B. A., & Cherni, L. (2021) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1744 · Cited by 1
Novel mechanisms of Stat3 activation
Arulanandam, R. (2010) · QSpace (Queen's University Library) · Cited by 1
The Molecular Pathogenesis of Haemangioma
Vishvanath, A. (2008) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16945627.v1 · Cited by 1
Transcription Factors Stat5a/b and Stat3 in Prostate Cancer Growth and Metastases
Mirtti, T. K., Talati, P. G., & Nevalainen, M. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2558-4_10
Reduced corticosteroid sensitivity in smokers with asthma : potential mechanisms and treatment
Spears, M. (2009) · Enlighten: Theses (The University of Glasgow)
(2014) · Cancer Cell & Microenvironment · doi:10.14800/ccm.351
Greeley, N. R. (2012) · Digital Commons-TMC (Texas Medical Center)
Transcription Factor Binding to DNA Mechanisms of Unphosphorylated STAT3
Dritschilo, A., Brown, M. L., Zhang, L., Korostyshevskiy, V. R., Tarasov, S. G., Tarasova, N. I., Timofeeva, A. V., & Chasovskikh, S. (2013)
Huang, W. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/310
Prevention and Treatment of Head and Neck Cancer with Natural Compound Inhibitors of STAT3
Leeman‐Neill, R. J. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
Functional studies of Tyk2 in IFNalpha signaling : a new interactor and an activating mutationPreprint
Gakovic, M. (2007)
Cellular Changes and Effects of Cytokines in the Transformation of Human Mammary Epithelial Cells
Kan, C. E. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
Liongue, C., Lewis, R. S., & Ward, A. C. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-42949-6_1
IL-6 Signals Through pStat3 to Prevent Functional Immune Suppression by Human Regulatory T Cells
Goodman, W. A. (2010) · OhioLink ETD Center (Ohio Library and Information Network)
Torti, D. (2012) · TSpace (University of Toronto)
Zhang, P. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
Cardoso, B. M., Letra‐Vilela, R., Silva‐Almeida, C., Rocha, A. M., Murtinheira, F., Branco‐Santos, J., Rodrı́guez, C., Martı́n, V., Santa‐Marta, M., & Herrera, F. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/546523
Zhang, X. (2011) · Journal of International Crisis and Risk Communication Research
JAK/STAT Signaling in Myeloid Cells
Priceman, S. J., Deng, J., Jove, R., & Yu, H. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394296-8.00026-9 · Cited by 1
Targeting JAK/STAT signalling for sensitization of colorectal cancer cells to chemoradiotherapy
Koerdel, K. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8719
The JAK–STAT–SOCS Signaling Cascade
Murphy, J. M., Babon, J. J., Nicola, N. A., & Nicholson, S. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.30016-5
Pectasides, E., Egloff, A. M., Sasaki, C. T., Kountourakis, P., Burtness, B. A., Fountzilas, G., Dafni, U. G., Zaramboukas, T., Rampias, T. N., Rimm, D. L., et al. (2023) · doi:10.1158/1078-0432.c.6519452
Zhang, L., Gao, L., Yang, L., Lin, G., Shao, Y., Ji, K., Yu, H. N., Hu, J., Kalvakolanu, D. V., Kopecko, D. J., et al. (2023) · doi:10.1158/1078-0432.c.6518118
Pectasides, E., Egloff, A. M., Sasaki, C. T., Kountourakis, P., Burtness, B. A., Fountzilas, G., Dafni, U. G., Zaramboukas, T., Rampias, T. N., Rimm, D. L., et al. (2023) · doi:10.1158/1078-0432.c.6519452.v1
Zhang, L., Gao, L., Yang, L., Lin, G., Shao, Y., Ji, K., Yu, H. N., Hu, J., Kalvakolanu, D. V., Kopecko, D. J., et al. (2023) · doi:10.1158/1078-0432.c.6518118.v1
Li, J., Diao, S., Li, L., Zhang, J., Ji, M.-L., Sun, L., Shen, W.-W., Wu, S., Chen, Z., & Huang, C. (2024) · Research Square · doi:10.21203/rs.3.rs-3723244/v1
TFF3 sensitizes cervical carcinoma cells to cisplatin toxicity by binding to IGF2R
Zhang, Y., Yan, L., An, N., Geng, J., Zhao, W., Feng, B., Zheng, Y., Liang, S., & Yang, L. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00990-w
Oncogene functions in human cancer
Tang, J. (2010) · ResearchSpace (University of Auckland)
Additional file 1 of NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma
Devitt, L., Westphal, D., Pieger, K., Schneider, N., Bosserhoff, A. K., & Kuphal, S. (2024) · Figshare · doi:10.6084/m9.figshare.25754951
Additional file 2 of NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma
Devitt, L., Westphal, D., Pieger, K., Schneider, N., Bosserhoff, A. K., & Kuphal, S. (2024) · Figshare · doi:10.6084/m9.figshare.25754973
Nakatani, Y., Takara, R., Murata, A., Yaguchi, M., 託, 天., & Yamamoto, N. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.042
RNAi modulation of endothelial-STAT3 as a therapeutic target for CAR T-cell toxicities
Rosén, R., Apte, V., Yang, J. H., Schloss, R. S., & Yarmush, M. L. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e44616
Self-citation
Metadata
- Authors
- Yang, J., Chatterjee-Kishore, M., Staugaitis, S. M., Nguyen, H., Schlessinger, K., Levy, D. E., & Stark, G. R.
- Affiliations
- 1Molecular Biology and Departments of
- Cleveland Clinic (US)
- New York University (US)
- Venue
- Cancer Research
- Published
- 2005-02-01
- Volume
- 65
- Issue
- 3
- Pages
- 939-947
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2147314043
- Cited by
- 405
- References
- 38
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 14 · 2021: 14 · 2020: 16 · 2019: 13 · 2018: 20 · 2017: 18 · 2016: 20 · 2015: 19 · 2014: 22 · 2013: 29 · 2012: 24
- FWCI
- 12.95
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cleveland Clinic
- Johns Hopkins University
- National Institutes of Health
- School of Medicine, Indiana University
- National Cancer Institute (P01CA062220)
- National Institute of Allergy and Infectious Diseases (R01AI028900)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT3, tyrosine 705 phosphorylation, carcinogenesis, transcriptional regulation, interleukin-6, cytokine response, oncoprotein, mineralocorticoid receptor antagonists, MET, constitutive STAT3 activation, gene expression, mammary epithelial cells
- MeSH terms
- Animals, DNA-Binding Proteins, Female, Gene Expression Regulation, Humans, Neoplasms, Oncogenes, Phosphorylation, Proto-Oncogene Proteins, RNA, Messenger, Trans-Activators, Interleukin-6, Gene Expression Regulation, Neoplastic, Receptors, Growth Factor, ras Proteins, Proto-Oncogene Proteins c-met, Monomeric GTP-Binding Proteins, Mammary Glands, Human, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review